Topics

Dr Reddy's demand more than $70 million from Indivior over generic Suboxone Film

06:36 EDT 12 Mar 2019 | Pharmafile

Indian firm Dr Reddy’s is seeking at least $70 million from British firm Indivior Plc as compensation for lost sales of its generic version of Indivior’s opioid addiction treatment Suboxone Film.

In July of last year, Indivior managed to block the entry of Dr Reddy’s generic version of Suboxone Film into the US market, despite Dr Reddy’s having received approval to sell their opioid disorder drug.

However a US Supreme Court last month refused to uphold the injunction, thus allowing Dr Reddy’s to re-enter the market.

read more

Original Article: Dr Reddy's demand more than $70 million from Indivior over generic Suboxone Film

NEXT ARTICLE

More From BioPortfolio on "Dr Reddy's demand more than $70 million from Indivior over generic Suboxone Film"

Quick Search

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...